Fang Lu

685 total citations
33 papers, 468 citations indexed

About

Fang Lu is a scholar working on Molecular Biology, Ophthalmology and Pathology and Forensic Medicine. According to data from OpenAlex, Fang Lu has authored 33 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Ophthalmology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Fang Lu's work include Glaucoma and retinal disorders (9 papers), Retinal Diseases and Treatments (5 papers) and Renal Diseases and Glomerulopathies (4 papers). Fang Lu is often cited by papers focused on Glaucoma and retinal disorders (9 papers), Retinal Diseases and Treatments (5 papers) and Renal Diseases and Glomerulopathies (4 papers). Fang Lu collaborates with scholars based in China and United States. Fang Lu's co-authors include Muhammad Saeed, Ercole L. Cavalieri, Muhammad Zahid, Eleanor G. Rogan, Nilesh W. Gaikwad, James E. Krause, Neil W. Kowall, Barry E. Kosofsky, Robert J. Ferrante and Mohamed F. Ali and has published in prestigious journals such as PLoS ONE, Scientific Reports and Free Radical Biology and Medicine.

In The Last Decade

Fang Lu

29 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fang Lu China 14 198 109 83 69 56 33 468
Craig Fairbairn United States 8 204 1.0× 137 1.3× 56 0.7× 43 0.6× 92 1.6× 12 573
Karen Aughton United Kingdom 10 215 1.1× 38 0.3× 54 0.7× 39 0.6× 35 0.6× 15 397
Xiuju Chen China 12 158 0.8× 34 0.3× 43 0.5× 31 0.4× 21 0.4× 35 423
Mohammad Keramatipour Iran 13 260 1.3× 122 1.1× 60 0.7× 24 0.3× 22 0.4× 60 549
Károly Szekeres United States 12 208 1.1× 68 0.6× 134 1.6× 119 1.7× 29 0.5× 18 572
Zhenlian Wang China 12 378 1.9× 32 0.3× 62 0.7× 111 1.6× 54 1.0× 19 615
Noboru Satozawa Japan 8 178 0.9× 41 0.4× 46 0.6× 34 0.5× 17 0.3× 8 469
Mohamed Adam Canada 16 290 1.5× 55 0.5× 35 0.4× 44 0.6× 37 0.7× 18 520
Christine Shugrue United States 14 337 1.7× 38 0.3× 57 0.7× 146 2.1× 55 1.0× 22 717

Countries citing papers authored by Fang Lu

Since Specialization
Citations

This map shows the geographic impact of Fang Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fang Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fang Lu more than expected).

Fields of papers citing papers by Fang Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fang Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fang Lu. The network helps show where Fang Lu may publish in the future.

Co-authorship network of co-authors of Fang Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Fang Lu. A scholar is included among the top collaborators of Fang Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fang Lu. Fang Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Fang, Shuisheng Hou, Chang Liu, et al.. (2025). Clinical significance of focal segmental glomerulosclerosis subclassification in IgA nephropathy. Nephrology Dialysis Transplantation. 41(2). 297–308. 1 indexed citations
2.
Lu, Fang, Shiyi Chen, Honglei Guo, et al.. (2025). Exploring immunological alterations of B cells in peripheral immunity via single-cell RNA sequencing: insights into primary membranous nephropathy. Frontiers in Immunology. 16. 1622395–1622395.
3.
He, Chong, Xiao Xiao, Donghua Liu, et al.. (2024). Th1 cells contribute to retinal ganglion cell loss in glaucoma in a VCAM-1-dependent manner. Journal of Neuroinflammation. 21(1). 43–43. 3 indexed citations
4.
Wang, Qiuyue, Shuyu Liu, Pingping Chen, et al.. (2024). Evaluation of drug interactions of Saposhnikoviae Radix and its major components with astragaloside IV and paeoniflorin using in vitro and in vivo experiments. Journal of Chromatography A. 1723. 464716–464716. 1 indexed citations
5.
Duan, Suyan, Fang Lu, Rui Sun, et al.. (2024). 25(OH)D level and vascular lesion scores in kidney histopathology as risk-stratification tool for predicting renal progression in people with type 2 diabetes. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 18(5). 103037–103037.
6.
Liu, Donghua, Hang Yuan, An Li, et al.. (2024). Association of plasma lactoferrin levels with disease severity in glaucoma patients. Frontiers in Medicine. 11. 1385358–1385358. 5 indexed citations
7.
Duan, Suyan, Si Chen, Fang Lu, et al.. (2023). Serum 25-hydroxyvitamin D as a predictive biomarker of clinical outcomes in patients with primary membranous nephropathy. Frontiers in Nutrition. 10. 1171216–1171216. 1 indexed citations
8.
He, Chong, et al.. (2023). Automatic measurement of anterior chamber angle parameters in AS-OCT images using deep learning. Biomedical Optics Express. 14(4). 1378–1378. 6 indexed citations
9.
He, Chong, et al.. (2023). Comprehensive assessment of the anterior segment in refraction corrected OCT based on multitask learning. Biomedical Optics Express. 14(8). 3968–3968. 3 indexed citations
10.
He, Chong, Gao Zhang, Rui Zhang, et al.. (2022). Clinical Significance of Albumin‐ and Bilirubin‐Based Biomarkers in Glaucoma: A Retrospective Case‐Control Study. Oxidative Medicine and Cellular Longevity. 2022(1). 8063651–8063651. 7 indexed citations
11.
Duan, Suyan, Fang Lu, Buyun Wu, et al.. (2022). Association of Serum 25 (OH) Vitamin D With Chronic Kidney Disease Progression in Type 2 Diabetes. Frontiers in Endocrinology. 13. 929598–929598. 10 indexed citations
12.
Jiang, Qin, Keli Huang, Fang Lu, et al.. (2021). Modifying strategies for SDF-1/CXCR4 interaction during mesenchymal stem cell transplantation. General Thoracic and Cardiovascular Surgery. 70(1). 1–10. 23 indexed citations
13.
Qu, Zheng, Shuohui Yang, Feng Xing, et al.. (2021). Magnetic resonance quantitative susceptibility mapping in the evaluation of hepatic fibrosis in chronic liver disease: a feasibility study. Quantitative Imaging in Medicine and Surgery. 11(4). 1170–1183. 13 indexed citations
15.
Peng, Kun, Jie Xiao, Jinxia Wang, et al.. (2020). MAdCAM-1 mediates retinal neuron degeneration in experimental colitis through recruiting gut-homing CD4+ T cells. Mucosal Immunology. 14(1). 152–163. 17 indexed citations
16.
Wu, Li, Joanne Kwak‐Kim, Ran Zhang, et al.. (2018). Vitamin D level affects IVF outcome partially mediated via Th/Tc cell ratio. American Journal of Reproductive Immunology. 80(6). e13050–e13050. 13 indexed citations
17.
Zhang, Lin, Yeming Yang, Shujin Li, et al.. (2017). Loss of Tmem30a leads to photoreceptor degeneration. Scientific Reports. 7(1). 9296–9296. 23 indexed citations
18.
Kang, Ning, Jianhua Zhou, Li‐Fang Wang, et al.. (2009). Adoptive immunotherapy of lung cancer with immobilized anti-TCRγδ antibody-expanded human γδ T Cells in peripheral blood. Cancer Biology & Therapy. 8(16). 1540–1549. 42 indexed citations
19.
Zahid, Muhammad, Nilesh W. Gaikwad, Mohamed F. Ali, et al.. (2008). Prevention of estrogen–DNA adduct formation in MCF-10F cells by resveratrol. Free Radical Biology and Medicine. 45(2). 136–145. 47 indexed citations
20.
Kowall, Neil W., et al.. (1993). Substance P and substance P receptor histochemistry in human neurodegenerative diseases. Regulatory Peptides. 46(1-2). 174–185. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026